Status:
UNKNOWN
Clinical Study of Transcriptome-based Diagnostic Biomarker for Acute Febrile Illness
Lead Sponsor:
Qilu Hospital of Shandong University
Conditions:
Acute Febrile Illness
Eligibility:
All Genders
14+ years
Brief Summary
Acute febrile illness is the main cause of outpatient visits，and bacterial and viral infections remains the most common cause. The diagnosis of infection is still based on symptoms and traditional tec...
Detailed Description
Acute fever is a common medical emergency worldwide, most often caused by bacterial or viral infections. Early and rapid differential diagnosis of infectious diseases is crucial for improving patient ...
Eligibility Criteria
Inclusion
- 1\. axillary temperature ≥38°C; 2. duration of fever shorter than 14 days; 3. subjects who are fully informed and agree to participate in this study.
Exclusion
- having comorbidities that may affect host gene expression, such as advanced malignancy, autoimmune diseases，immunodeficiency, or taking immune suppressors; 2.pregnancy; 3. mixed infection (viral combined with bacterial infection, autoimmune disease combined with bacterial infection); 4.incomplete clinical information; 5. For safety reasons or the interests of patients, clinicians believe that patients should not participate in any situation in this study.
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2025
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT06552975
Start Date
September 1 2021
End Date
August 30 2025
Last Update
August 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qilu Hospital of Shandong University
Jinan, Shandong, China, 250012